Cargando…
High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders
BACKGROUND: To address the clinical and virological significance of a high HTLV-1 proviral load (VL) in practical blood samples from asymptomatic and symptomatic carriers, we simultaneously examined VL and clonal expansion status using polymerase chain reaction (PCR) quantification (infected cell %...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876101/ https://www.ncbi.nlm.nih.gov/pubmed/20423527 http://dx.doi.org/10.1186/1743-422X-7-81 |
_version_ | 1782181661377560576 |
---|---|
author | Sasaki, Daisuke Doi, Yuko Hasegawa, Hiroo Yanagihara, Katsunori Tsukasaki, Kunihiro Iwanaga, Masako Yamada, Yasuaki Watanabe, Toshiki Kamihira, Shimeru |
author_facet | Sasaki, Daisuke Doi, Yuko Hasegawa, Hiroo Yanagihara, Katsunori Tsukasaki, Kunihiro Iwanaga, Masako Yamada, Yasuaki Watanabe, Toshiki Kamihira, Shimeru |
author_sort | Sasaki, Daisuke |
collection | PubMed |
description | BACKGROUND: To address the clinical and virological significance of a high HTLV-1 proviral load (VL) in practical blood samples from asymptomatic and symptomatic carriers, we simultaneously examined VL and clonal expansion status using polymerase chain reaction (PCR) quantification (infected cell % of peripheral mononuclear cells) and Southern blotting hybridization (SBH) methods. RESULTS: The present study disclosed extremely high VL with highly dense smears with or without oligoclonal bands in SBH. A high VL of 10% or more was observed in 16 (43.2%) of a total of 33 samples (one of 13 asymptomatic carriers, 8 of 12 symptomatic carriers, and 7 of 8 patients with lymphoma-type ATL without circulating ATL cells). In particular, an extremely high VL of 50% or more was limited to symptomatic carriers whose band findings always contained at least dense smears derived from polyclonally expanded cells infected with HTLV-1. Sequential samples revealed that the VL value was synchronized with the presence or absence of dense smears, and declined at the same time as disappearing dense smears. Dense smears transiently emerged at the active stage of the underlying disease. After disappearance of the smears, several clonal bands became visible and were persistently retained, explaining the process by which the clonality of HTLV-1-infected cells is established. The cases with only oligoclonal bands tended to maintain a stable VL of around 20% for a long time. Two of such cases developed ATL 4 and 3.5 years later, suggesting that a high VL with oligoclonal bands may be a predisposing risk to ATL. CONCLUSION: The main contributor to extremely high VL seems to be transient emergence of dense smears detected by the sensitivity level of SBH, corresponding to polyclonal expansion of HTLV-1-infected cells including abundant small clones. Major clones retained after disappearance of dense smears stably persist and acquire various malignant characteristics step by step. |
format | Text |
id | pubmed-2876101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-28761012010-05-26 High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders Sasaki, Daisuke Doi, Yuko Hasegawa, Hiroo Yanagihara, Katsunori Tsukasaki, Kunihiro Iwanaga, Masako Yamada, Yasuaki Watanabe, Toshiki Kamihira, Shimeru Virol J Research BACKGROUND: To address the clinical and virological significance of a high HTLV-1 proviral load (VL) in practical blood samples from asymptomatic and symptomatic carriers, we simultaneously examined VL and clonal expansion status using polymerase chain reaction (PCR) quantification (infected cell % of peripheral mononuclear cells) and Southern blotting hybridization (SBH) methods. RESULTS: The present study disclosed extremely high VL with highly dense smears with or without oligoclonal bands in SBH. A high VL of 10% or more was observed in 16 (43.2%) of a total of 33 samples (one of 13 asymptomatic carriers, 8 of 12 symptomatic carriers, and 7 of 8 patients with lymphoma-type ATL without circulating ATL cells). In particular, an extremely high VL of 50% or more was limited to symptomatic carriers whose band findings always contained at least dense smears derived from polyclonally expanded cells infected with HTLV-1. Sequential samples revealed that the VL value was synchronized with the presence or absence of dense smears, and declined at the same time as disappearing dense smears. Dense smears transiently emerged at the active stage of the underlying disease. After disappearance of the smears, several clonal bands became visible and were persistently retained, explaining the process by which the clonality of HTLV-1-infected cells is established. The cases with only oligoclonal bands tended to maintain a stable VL of around 20% for a long time. Two of such cases developed ATL 4 and 3.5 years later, suggesting that a high VL with oligoclonal bands may be a predisposing risk to ATL. CONCLUSION: The main contributor to extremely high VL seems to be transient emergence of dense smears detected by the sensitivity level of SBH, corresponding to polyclonal expansion of HTLV-1-infected cells including abundant small clones. Major clones retained after disappearance of dense smears stably persist and acquire various malignant characteristics step by step. BioMed Central 2010-04-28 /pmc/articles/PMC2876101/ /pubmed/20423527 http://dx.doi.org/10.1186/1743-422X-7-81 Text en Copyright ©2010 Sasaki et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Sasaki, Daisuke Doi, Yuko Hasegawa, Hiroo Yanagihara, Katsunori Tsukasaki, Kunihiro Iwanaga, Masako Yamada, Yasuaki Watanabe, Toshiki Kamihira, Shimeru High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders |
title | High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders |
title_full | High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders |
title_fullStr | High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders |
title_full_unstemmed | High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders |
title_short | High Human T Cell Leukemia Virus Type-1(HTLV-1) Provirus Load in Patients with HTLV-1 Carriers Complicated with HTLV-1-unrelated disorders |
title_sort | high human t cell leukemia virus type-1(htlv-1) provirus load in patients with htlv-1 carriers complicated with htlv-1-unrelated disorders |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2876101/ https://www.ncbi.nlm.nih.gov/pubmed/20423527 http://dx.doi.org/10.1186/1743-422X-7-81 |
work_keys_str_mv | AT sasakidaisuke highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders AT doiyuko highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders AT hasegawahiroo highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders AT yanagiharakatsunori highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders AT tsukasakikunihiro highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders AT iwanagamasako highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders AT yamadayasuaki highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders AT watanabetoshiki highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders AT kamihirashimeru highhumantcellleukemiavirustype1htlv1provirusloadinpatientswithhtlv1carrierscomplicatedwithhtlv1unrelateddisorders |